Effectiveness of asoprisnil, a selective progesterone receptor modulator (SPRM) in treating uterine leiomyomata. Advances in Uterine Leiomyoma

Non ancora tradotto Non ancora tradotto
Categoria Primary study
GiornaleNIH International Congress
Year 2005

Questo articolo fa parte di 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: e4a79194792bc0fc8ab3b4b228f3402bf87ff99e
First added on: May 12, 2020